Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has heart failure classified as New York Heart Association (NYHA) Class III or Class IV at screening despite treatment with standard therapy.
Is able to perform a treadmill test.
Has an HbA1c of \<= 11%.
Is physically and mentally capable of operating the continuous subcutaneous infusion (CSCI) pump (i.e., adequate vision, manual dexterity, and mental capacity), or has a dedicated caretaker or adult family member who meets this requirement.
You may not be if
Has received metformin or nesiritide within 2 weeks prior to screening visit.
Is currently participating in any other clinical study, or has received an investigational drug within 1 month of the screening period.
Has participated previously in a study using GLP-1, exenatide, or exenatide LAR.
Is using a left ventricular assist device or other mechanical circulatory support.
